Advances in Chronic Kidney Disease
Volume 14, Issue 1 , Pages 79-81 , January 2007

Chronic Kidney Disease Care and Medicare Reimbursement for Preventive Services

  • Dolph Chianchiano

      Affiliations

    • Corresponding Author InformationAddress correspondence to Dolph Chianchiano, c/o National Kidney Foundation, Inc, E. 33 Street, New York, NY 10016.

References 

  1. Section 612 of MMA is entitled: “Coverage of Cardiovascular Screening Blood Tests.” The heading for Section 613 of MMA is: “Coverage of Diabetes Screening Tests.” Public Law 108-163.
  2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1047–1052
  3. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober K, Rouleau JL, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351:1285–1295
  4. KEEP Annual Data Report. Am J Kidney Dis. 2005;6(suppl 3):6
  5. de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, et al. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation. 2004;110:921–927
  6. US Preventive Services Task Force. Recommendations on Screening for Hematuria and Proteinuria by Dipstick Urinalysis. JAMA. 1989;262:1214

PII: S1548-5595(06)00170-4

doi: 10.1053/j.ackd.2006.10.008

Advances in Chronic Kidney Disease
Volume 14, Issue 1 , Pages 79-81 , January 2007

Article Tools